The role of hypnotherapy for the treatment of inflammatory bowel diseases

Expert Review of Gastroenterology and Hepatology

Volumn 8, Issue 6, 2014, Pages 601-606

  Moser, Gabriele ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

brain gut axis; hypnosis; inflammatory bowel diseases; integrated care; psychological distress; psychotherapy; treatment

Indexed keywords

CORTICOSTEROID;

ANXIETY; ARTICLE; AUTOIMMUNE DISEASE; BRAIN; COPING BEHAVIOR; CROHN DISEASE; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISTRESS SYNDROME; GUT DIRECTED HYPNOTHERAPY; HUMAN; HYPNOSIS; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE; NONHUMAN; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CONCEPT; ULCERATIVE COLITIS; COMPLICATION; INFLAMMATORY BOWEL DISEASES; MENTAL STRESS; PSYCHOLOGY; QUALITY OF LIFE; REMISSION; TREATMENT OUTCOME;

HUMANS; HYPNOSIS; INFLAMMATORY BOWEL DISEASES; QUALITY OF LIFE; REMISSION INDUCTION; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 84904471784     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2014.917955     Document Type: Article

References (53)

1. Fuller-Thomson E, Sulman J. Depression and inflammatory. bowel disease: Findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12: 697-707
2. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: A population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008;103(8): 1989-97
3. Koschke M, Boettger MK, Schulz S, et al. Autonomy of autonomic dysfunction in major depression. Psychosom Med 2009; 71(8):852-60
4. Bitton A, Sewitch MJ, Peppercorn MA, et al. Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study. Am J Gastroenterol 2003;98:2203-8
5. Bitton A, Dobkin PL, Edwardes MD, et al. Predicting relapse in Crohn's disease: A biopsychosocial model. Gut 2008;57(10): 1386-92
6. Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991;17:101-10
7. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease-A prospective 18 months follow up study. Psychosom Med 2004;66:79-84
8. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95: 1213-20
9. Mawdsley J, Macey M, Feakins R, et al. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 2006;131:410-19
10. Maunder R, Greenberg G, Hunter J, et al. Psychobiological subtypes of ulcerative colitis: PANCA status moderates the relationship between disease activity and psychological distress. Am J Gastroenterol 2006;101:2546-51
11. Langhorst J, Hofstetter A, Wolfe F, Häuser W. Short-Term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: A prospective 12-month follow-up study. Inflamm Bowel Dis 2013;19(11):2380-6
12. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010;105(9):1994-2002
13. Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144(1):36-49
14. Meregnani J, Clarençon D, Vivier M, et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci 2011; 160(1-2):82-9
15. Häuser W, Moser G, Klose P, Mikocka-Walus A. Are statements and recommendations on psychosocial issues included in evidence-based guidelines on the management of inflammatory bowel diseases?. A systematic review. World J Gastroenterol 2014;20(13):3663-71
16. Goodhand JR, Wahed M, Rampton DS Management of stress in inflammatory bowel disease: A therapeutic option?. Expert Rev Gastroenterol Hepatol 2009;3(6): 661-79
17. Miehsler W, Weichselberger M, Offerlbauer-Ernst A, et al. Assessing the demand for psychological care in chronic diseases: Development and validation of a questionnaire based on the example of inflammatory bowel disease. Inflamm Bowel Dis 2004;10(5):637-45
18. Timmer A, Preiss JC, Motschall E, et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011;16(2):CD006913
19. McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: A review and update. J Crohns Colitis 2013;7(12):935-49
20. Knowles SR, Monshat K, Castle DJ. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: A review. Inflamm Bowel Dis 2013;19(12):2704-15
21. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984;2:1232-4
22. Whorwell PJ. IBS: Hypnotherapy-A wasted resource?. Nat Rev Gastroenterol Hepatol 2011;9(1):12-13
23. Palsson OS. Standardized hypnosis treatment for irritable bowel syndrome: The North Carolina protocol. Int J Clin Exp Hypn 2006;54:51-64
24. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut 1987;28: 423-5
25. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003;52:1623-9
26. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome-The effect of hypnotherapy. Aliment Pharmacol Ther 1996;10:91-5
27. Moser G, Trägner S, Gajowniczek EE, et al. Long-Term success of gut-directed group hypnosis for patients with refractory irritable bowel syndrome-A randomized controlled trial. Am J Gastroenterol 2013;108(4):602-9
28. Schaefert R, Klose P, Moser G, Häuser W. Efficacy, tolerability and safety of hypnosis in adult irritable bowel syndrome-systematic review and meta-Analysis. Psychosom Med 2014;In press
29. Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990;31:896-8
30. Lea R, Houghton LA, Calvert EL, et al. Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:635-42
31. Simrén M, Ringström G, Björnsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med 2004;66(2):233-8
32. Francis CY, Houghton LA. Use of hypnotherapy in gastrointestinal disorders. Eur J Gastroenterol Hepatol 1996;8:525-9
33. Jones H, Cooper P, Miller V, et al. Treatment of non-cardiac chest pain: A controlled trial of hypnotherapy. Gut 2006;55:10-1403-8
34. Calvert EL, Houghton LA, Cooper P, et al. Long-Term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002;123(6):1778-85
35. Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms. Dig Dis Sci 2002;47:2605-14
36. Klein KB, Spiegel D. Modulation of gastric acid secretion by hypnosis. Gastroenterology 1989;96(6):1383-7
37. Gonsalkorale WM, Toner BB, Whorwell PJ. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. J Psychosom Res 2004;56(3):271-8
38. Lowén MB, Mayer EA, Sjöberg M, et al. Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013;37(12): 1184-97
39. Lindfors P, Törnblom H, Sadik R, et al. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS). Scand J Gastroenterol 2012;47(12):1480-7
40. Vlieger AM, van Den Berg MM, Menko-Frankenhuis C, et al. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2010;105(1):213-18
41. Mawdsley JE, Jenkins DG, Macey MG, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol 2008;103(6):1460-9
42. Peter JM, Tran US, Michalski M, Moser G. Irritable bowel syndrome and psychological comorbidity-long-Term success of gut-directed group hypnosis. Psychother Psychosom 2013;82(suppl 1):84
43. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. Inflamm Bowel Dis 2006;12(1):38-46
44. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: Special situations. J Crohns Colitis 2013;7(11):1-33
45. Schäfer DW. Hypnosis and the treatment of ulcerative colitis and Crohn's disease. Am J Clin Hypn 1997;40(2):111-17
46. Keefer L, Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: A brief communication. Int J Clin Exp Hypn 2007; 55(4):457-66
47. Miller V, Whorwell PJ. Treatment of inflammatory bowel disease: A role for hypnotherapy?. Int J Clin Exp Hypn 2008; 56(3):306-17
48. Emami MH, Gholamrezaei A, Daneshgar H. Hypnotherapy as an adjuvant for the management of inflammatory bowel disease: A case report. Am J Clin Hypn 2009;51(3): 255-62
49. Keefer L, Taft TH, Kiebles JL, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 2013;38(7):761-71
50. Greifenegg M, Michalski M, Dejaco C, Moser G. Gut directed hypnosis for patients with inflammatory bowel diseases (IBD). Psychother Psychosom 2013;82(suppl 1):39
51. Dür M, Sadlonova M, Haider S, et al. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis 2014;8:45-55
52. Hutfless SM, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007;133:1779-86
53. Mikocka-Walus AA, Andrews JA, Bernstein CN, et al. The integrated approach to managing inflammatory bowel disease (IBD): A discussion paper on various integrated models of care. Inflamm Bowel Dis 2012;18(8):1582-7